ImpriMed, which builds AI-powered drug response prediction tech to help treat cancer in dogs and cats, raised a $23M Series A led by SoftBank Ventures Asia

The Techmeme archive page for December 21, 2023, provides a comprehensive roundup of the day's top tech news, featuring articles from various sources including Substack, Tech Policy Press, The Popehat Report, New.blicio.us, Reason, and Pixel Envy. The news covers a wide range of topics, from policy and industry updates to product launches and reviews. The page also highlights discussions from key figures in the tech industry, with threads from Twitter handles such as @benedictevans, @renee.diresta, @brian.fishman.5, and others.

In addition to the news, the page also includes sections for sponsor posts, job listings in tech, and upcoming tech events. It also provides a snapshot of how the site appeared at 11:30 PM ET on December 21, 2023. The page also features news from Mediagazer, a sister site focusing on media news. The page ends with a section for earlier picks, featuring more tech news and discussions from various sources and individuals.

Key takeaways

I'm sorry, but the provided text doesn't contain a specific article or clear points that can be summarized into key bullet points. It appears to be a list of references, mentions, and sources from a tech news aggregation site. Please provide a specific article or text for summarization.

ImpriMed, which builds AI-powered drug response prediction tech to help treat cancer in dogs and cats, raised a $23M Series A led by SoftBank Ventures Asia

Key takeaways

Discussion (0)